학술논문
A novel clinically applicable biomarker for testing HRD status based on the mutational signatures: Results for the phase 2 trial of olaparib maintenance monotherapy in patients with primary high-grade ovarian carcinoma (2271)
Document Type
Abstract
Author
Oda, Katsutoshi; Nishijima, Akira; Hasegawa, Kosei; Sato, Sho; Kato, Kazuyoshi; Mori, Mayuyo; Nagao, Shoji; Matsumura, Noriomi; Kagabu, Mahahiro; Takenaka, Masataka; Yoshihara, Kosuke; Konno, Yosuke; Hamanishi, Junzo; Tokunaga, Hideki; Ogasawara, Aiko; Ueda, Keiko; Kashiwabara, Kosuke; Aoki, Takashi; Nishimura, Kunihiro; Tatsuno, Kenji; Aburatani, Hiroyuki
Source
In Gynecologic Oncology September 2023 176 Supplement 1:S297-S298
Subject
Language
ISSN
0090-8258